# Selegiline to Zelapar Switch Study in Parkinson Disease Patients

> **NCT00640159** · PHASE4 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 48 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Zelapar

## Key facts

- **NCT ID:** NCT00640159
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2008-06
- **Final completion:** 2008-08
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2023-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00640159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00640159, "Selegiline to Zelapar Switch Study in Parkinson Disease Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00640159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*